Charles River Laboratories International (CRL) Profit Margin (2009 - 2026)
Charles River Laboratories International (CRL) profit margin from Jun 27, 2009 to Mar 28, 2026. The current Charles River Laboratories International (CRL) profit margin is -1.49%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Charles River Laboratories International (CRL)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -3.59% | -755.78% |
| 2024 | 0.55% | -95.23% |
| 2023 | 11.49% | -6.01% |
| 2022 | 12.23% | +10.73% |
| 2021 | 11.04% | -11.36% |
| 2020 | 12.46% | +29.59% |
| 2019 | 9.61% | -11.80% |
| 2019 | 10.90% | +63.91% |
| 2019 | 6.65% | -27.07% |
| 2019 | 9.12% | -8.71% |
| 2018 | 9.99% | -3.15% |
| 2018 | 10.31% | +12.40% |
| 2018 | 9.18% | -13.87% |
| 2018 | 10.65% | +60.44% |
| 2017 | 6.64% | -41.25% |
| 2017 | 11.30% | -1.72% |
| 2017 | 11.50% | +9.58% |
| 2017 | 10.49% | +14.02% |
| 2016 | 9.20% | +3.83% |
| 2016 | 8.86% | +9.29% |
| 2016 | 8.11% | -22.49% |
| 2016 | 10.47% | -4.44% |
| 2015 | 10.95% | +2.39% |
| 2015 | 10.70% | -25.13% |
| 2015 | 14.29% | +45.13% |
| 2015 | 9.84% | +0.82% |
| 2014 | 9.76% | -0.18% |
| 2014 | 9.78% | -5.36% |
| 2014 | 10.33% | -4.01% |
| 2014 | 10.77% | +22.03% |
| 2013 | 8.82% | -16.51% |
| 2013 | 10.57% | +13.47% |
| 2013 | 9.31% | +6.03% |
| 2013 | 8.78% | +1.37% |
| 2012 | 8.66% | -9.98% |
| 2011 | 9.62% | -132.40% |
| 2010 | -29.70% | -404.11% |
| 2009 | 9.77% | -124.12% |
| 2008 | -40.49% | N/A |
Comparison Charles River Laboratories International (CRL) profit margin with competitors
Charles River Laboratories International (CRL) profit margin is -1.49%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 24.41% | -1738.02% |
| VCYT | Veracyte Inc | 20.64% | -1485.04% |
| QGEN | Qiagen NV | 20.33% | -1464.23% |
| MTD | Mettler-Toledo International Inc | 17.89% | -1300.50% |
| MEDP | Medpace Holdings Inc | 17.53% | -1276.34% |
| DHR | Danaher Corp | 17.29% | -1260.24% |
| A | Agilent Technologies Inc | 16.96% | -1238.09% |
| BLLN | Billiontoone Inc - Class A | 16.58% | -1212.59% |
| TMO | Thermo Fisher Scientific Inc | 15.00% | -1106.57% |
| ILMN | Illumina Inc | 12.28% | -924.04% |
| SHC | Sotera Health Company | 9.49% | -736.82% |
| DGX | Quest Diagnostics Inc | 8.70% | -683.81% |
| LH | Laboratory Corp Of America Holdings | 7.85% | -626.77% |
| IQV | IQVIA Holdings Inc | 6.60% | -542.89% |
| FONR | Fonar Corp | 6.20% | -516.05% |
| RVTY | Revvity Inc | 5.73% | -484.51% |
| ICLR | Icon Plc | 2.78% | -286.55% |
| CDNA | Caredx Inc | 2.39% | -260.38% |